Skip to main content Accessibility help
×
Home

n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights

  • John K. Wachira (a1), Mark K. Larson (a2) and William S. Harris (a1) (a3) (a4)

Abstract

n-3 Fatty acids (EPA and DHA, from fish oil) are essential fatty acids that are approved for the treatment of severe hypertriacylglycerolaemia and, in some countries, used for reducing the risk of CVD. Because of their inhibitory effects on platelet function, some practitioners have, perhaps unnecessarily, discontinued their use in patients undergoing invasive procedures or being treated with anti-platelet or anticoagulation drugs. Thus, the aim of the present study was to review the effects of n-3 fatty acids on bleeding complications in a wide variety of clinical settings, and to summarise their biochemical mechanism of action in platelet function and coagulation. We surveyed recent publications that either directly studied the effects of n-3 fatty acids on the risk of bleeding or focused on different end-points and also reported the effects on bleeding. n-3 Fatty acid treatment had no effect on the risk of clinically significant bleeding in either monotherapy or combination therapy settings. Although originally believed to operate primarily via the cyclo-oxygenase system, these fatty acids have been shown to affect multiple signalling pathways and thrombotic processes beyond simply affecting platelet aggregation. The present overview found no support for discontinuing the use of n-3 fatty acid treatment before invasive procedures or when given in combination with other agents that affect bleeding. On the contrary, the use of these fatty acids in several settings improved clinical outcomes.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights
      Available formats
      ×

Copyright

Corresponding author

* Corresponding author: J. K. Wachira, fax +1 605 357 1311, email jkelly.wachira@usd.edu

References

Hide All
1 Dyerberg, J & Bang, HO (1979) Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet ii, 433435.
2 Dyerberg, J, Bang, HO, Stoffersen, E, et al. (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet ii, 117119.
3 Parkinson, AJ, Cruz, AL, Heyward, WL, et al. (1994) Elevated concentrations of plasma omega-3 polyunsaturated fatty acids among Alaskan Eskimos. Am J Clin Nutr 59, 384388.
4 Knapp, HR (1997) Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 65, Suppl., 1687S1698S.
5 Harris, WS (2007) Expert opinion: omega-3 fatty acids and bleeding – cause for concern? Am J Cardiol 99, S44S46.
6 Eritsland, J, Arnesen, H, Seljeflot, I, et al. (1995) Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis 6, 1722.
7 Gajos, G, Rostoff, P, Undas, A, et al. (2010) Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after PCI to modify responsiveness to dual antiplatelet therapy) study. J Am Coll Cardiol 55, 16711678.
8 Gajos, G, Zalewski, J, Rostoff, P, et al. (2011) Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI Clot). Arterioscler Thromb Vasc Biol 31, 16961702.
9 Gajos, G, Zalewski, J, Nessler, J, et al. (2012) Polyunsaturated omega-3 fatty acids improve responsiveness to clopidogrel after percutaneous coronary intervention in patients with cytochrome P450 2C19 loss-of-function polymorphism. Kardiol Pol 70, 439445.
10 Iacoviello, L, Amore, C, De, CA, et al. (1992) Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids. Arterioscler Thromb 12, 11911197.
11 Cairns, J, Gill, J, Morton, B, et al. (1996) Fish oils and low-molecular weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation 94, 15531560.
12 Yokoyama, M, Origasa, H, Matsuzaki, M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369, 10901098.
13 Tanaka, K, Ishikawa, Y, Yokoyama, M, et al. (2008) Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke 39, 20522058.
14 Cohen, MG, Rossi, JS, Garbarino, J, et al. (2011) Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel. Thromb Res 128, 335340.
15 Nilsen, DW, Dalaker, K, Nordoy, A, et al. (1991) Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery. Thromb Haemost 66, 195201.
16 Watson, PD, Joy, PS, Nkonde, C, et al. (2009) Comparison of bleeding complications with omega-3 fatty acids+aspirin+clopidogrel – versus – aspirin+clopidogrel in patients with cardiovascular disease. Am J Cardiol 104, 10521054.
17 Park, Y, Park, S, Yi, H, et al. (2009) Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res 29, 825830.
18 Salisbury, AC, Harris, WS, Amin, AP, et al. (2012) Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction. Am J Cardiol 109, 1318.
19 Harris, WS & von Schacky, C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212220.
20 Yoneda, H, Shirao, S, Kurokawa, T, et al. (2008) Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage? Acta Neurol Scand 118, 5459.
21 Lok, CE, Moist, L, Hemmelgarn, BR, et al. (2012) Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA 307, 18091816.
22 Ferraro, PM, Ferraccioli, GF, Gambaro, G, et al. (2009) Combined treatment with renin–angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial. Nephrol Dial Transplant 24, 156160.
23 Martin, JM & Stapleton, RD (2010) Omega-3 fatty acids in critical illness. Nutr Rev 68, 531541.
24 Friesecke, S, Lotze, C, Kohler, J, et al. (2008) Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 34, 14111420.
25 Kepler, CK, Huang, RC, Meredith, D, et al. (2012) Omega-3 and fish oil supplements do not cause increased bleeding during spinal decompression surgery. J Spinal Disord Tech 25, 129132.
26 Meredith, DS, Kepler, CK, Hirsch, B, et al. (2012) The effect of omega-3 fatty-acid supplements on perioperative bleeding following posterior spinal arthrodesis. Eur Spine J 21, 26592663.
27 Katan, MB, Deslypere, JP, van Birgelen, AP, et al. (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 20122022.
28 Heller, AR, Fischer, S, Rossel, T, et al. (2002) Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr 87, Suppl. 1, S95S101.
29 GISSI-HF, Investigators, Tavazzi, L, Maggioni, AP, et al. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 12231230.
30 Calo, L, Bianconi, L, Colivicchi, F, et al. (2005) N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45, 17231728.
31 Mozaffarian, D, Marchioli, R, Macchia, A, et al. (2012) Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 308, 20012011.
32 Krysiak, R & Okopien, B (2012) Hemostatic effects of omega-3 fatty acids in isolated hypertriglyceridemic patients treated with bezafibrate. Eur J Intern Med 23, e168e169.
33 Daak, AA, Ghebremeskel, K, Hassan, Z, et al. (2013) Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 97, 3744.
34 Olsen, SF & Joensen, HD (1985) High liveborn birth weights in the Faroes: a comparison between birth weights in the Faroes and in Denmark. J Epidemiol Community Health 39, 2732.
35 Olsen, SF, Secher, NJ, Tabor, A, et al. (2000) Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 107, 382395.
36 Elkhouli, AM (2011) The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study). J Periodontal Res 46, 261268.
37 Mozaffarian, D & Wu, JHY (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways and clinical events. J Am Coll Cardiol 58, 20472067.
38 He, K, Song, Y, Daviglus, ML, et al. (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109, 27052711.
39 Marchioli, R, Barzi, F, Bomba, E, et al. (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105, 18971903.
40 Gao, LG, Cao, J, Mao, QX, et al. (2013) Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials. Atherosclerosis 226, 328334.
41 Thorngren, M & Gustafson, A (1981) Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet ii, 11901193.
42 Lorenz, R, Spengler, U, Fischer, S, et al. (1983) Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 67, 504511.
43 Haines, AP, Sanders, TA, Imeson, JD, et al. (1986) Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics. Thromb Res 43, 643655.
44 Gibney, MJ & Bolton-Smith, C (1988) The effect of a dietary supplement of n-3 polyunsaturated fat on platelet lipid composition, platelet function and platelet plasma membrane fluidity in healthy volunteers. Br J Nutr 60, 512.
45 Harris, WS, Silveira, S & Dujovne, CA (1990) The combined effects of N-3 fatty acids and aspirin on hemostatic parameters in man. Thromb Res 57, 517526.
46 Driss, F, Vericel, E, Lagarde, M, et al. (1984) Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res 36, 389396.
47 Dona, M, Fredman, G, Schwab, JM, et al. (2008) Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848855.
48 Fredman, G, Van Dyke, TE & Serhan, CN (2010) Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol 30, 20052013.
49 Chen, P, Vericel, E, Lagarde, M, et al. (2011) Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J 25, 382388.
50 Lagarde, M, Calzada, C, Guichardant, M, et al. (2013) Dose-effect and metabolism of docosahexaenoic acid: pathophysiological relevance in blood platelets. Prostaglandins Leukot Essent Fatty Acids 88, 4952.
51 Kinsella, JE, Lokesh, B & Stone, RA (1990) Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 52, 128.
52 Siess, W, Roth, P, Scherer, B, et al. (1980) Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet i, 441444.
53 Bradlow, BA, Chetty, N, van der Westhuyzen, J, et al. (1983) The effects of a mixed fish diet on platelet function, fatty acids and serum lipids. Thromb Res 29, 561568.
54 Santos, MT, Valles, J, Aznar, J, et al. (2006) Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease. J Lab Clin Med 147, 220227.
55 Born, GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927929.
56 Dyszkiewicz-Korpanty, AM, Frenkel, EP & Sarode, R (2005) Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 11, 2535.
57 George, JN, Caen, JP & Nurden, AT (1990) Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 75, 13831395.
58 Burgess-Wilson, ME, Cockbill, SR, Johnston, GI, et al. (1987) Platelet aggregation in whole blood from patients with Glanzmann's thrombasthenia. Blood 69, 3842.
59 Bennett, JS, Hoxie, JA, Leitman, SF, et al. (1983) Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci U S A 80, 24172421.
60 Needleman, P, Whitaker, MO, Wyche, A, et al. (1980) Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacological basis for a therapeutic approach. Prostaglandins 19, 165181.
61 Brox, JH, Killie, JE, Osterud, B, et al. (1983) Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type IIa). Acta Med Scand 213, 137144.
62 von Schacky, C, Fischer, S & Weber, PC (1985) Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 76, 16261631.
63 Swann, PG, Venton, DL & Le Breton, GC (1989) Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett 243, 244246.
64 Swann, PG, Parent, CA, Croset, M, et al. (1990) Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. J Biol Chem 265, 2169221697.
65 Wada, M, DeLong, CJ, Hong, YH, et al. (2007) Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 282, 2225422266.
66 Larson, MK, Ashmore, JH, Harris, KA, et al. (2008) Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb Haemost 100, 634641.
67 Needleman, P, Raz, A, Minkes, MS, et al. (1979) Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A 76, 944948.
68 Whitaker, MO, Wyche, A, Fitzpatrick, F, et al. (1979) Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances. Proc Natl Acad Sci U S A 76, 59195923.
69 Boukhchache, D & Lagarde, M (1982) Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta 713, 386392.
70 Morita, I, Takahashi, R, Saito, Y, et al. (1983) Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid. J Biol Chem 258, 1019710199.
71 Larson, MK, Shearer, GC, Ashmore, JH, et al. (2011) Omega-3 fatty acids modulate collagen signaling in human platelets. Prostaglandins Leukot Essent Fatty Acids 84, 9398.
72 Guillot, N, Caillet, E, Laville, M, et al. (2009) Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J 23, 29092916.
73 Li, XL & Steiner, M (1990) Fish oil: a potent inhibitor of platelet adhesiveness. Blood 76, 938945.
74 Li, XL & Steiner, M (1991) Dose response of dietary fish oil supplementations on platelet adhesion. Arterioscler Thromb 11, 3946.
75 Del Turco, S, Basta, G, Lazzerini, G, et al. (2008) Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction. Haematologica 93, 892899.
76 Phang, M, Lincz, L, Seldon, M, et al. (2012) Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects. J Nutr Biochem 23, 11281133.
77 Harker, LA, Kelly, AB, Hanson, SR, et al. (1993) Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 87, 10171029.
78 Jerling, JC, Curiel-Martos, A, Kroner, C, et al. (2003) Fish oil inhibits photochemically induced thrombosis in the guinea pig in a dose dependent manner. Thromb Res 111, 1117.
79 Braden, GA, Knapp, HR, Fitzgerald, DJ, et al. (1990) Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator: evidence for a modest platelet inhibitory effect in vivo . Circulation 82, 178187.
80 Aarsetoy, H, Brugger-Andersen, T, Hetland, O, et al. (2006) Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction. Thromb Haemost 95, 329336.
81 Din, JN, Harding, SA, Valerio, CJ, et al. (2008) Dietary intervention with oil rich fish reduces platelet–monocyte aggregation in man. Atherosclerosis 197, 290296.
82 Moertl, D, Berger, R, Hammer, A, et al. (2011) Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure. Thromb Haemost 106, 457465.
83 Monroe, DM, Hoffman, M & Roberts, HR (2002) Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22, 13811389.
84 Tracy, PB, Nesheim, ME & Mann, KG (1981) Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J Biol Chem 256, 743751.
85 Vanschoonbeek, K, Feijge, MA, Paquay, M, et al. (2004) Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 24, 17341740.
86 Larson, MK, Tormoen, GW, Weaver, LJ, et al. (2013) Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation. Am J Physiol Cell Physiol 304, C273C279.
87 de Roos, B, Mavrommatis, Y & Brouwer, IA (2009) Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 158, 413428.
88 Xiong, JP, Stehle, T, Diefenbach, B, et al. (2001) Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294, 339345.

Keywords

n-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights

  • John K. Wachira (a1), Mark K. Larson (a2) and William S. Harris (a1) (a3) (a4)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed